
Disease-modifying anti-rheumatic drugs are a major contributor to specialty drug spending.

Disease-modifying anti-rheumatic drugs are a major contributor to specialty drug spending.

The American College of Rheumatology said a recent Medicare rule may affect prescription drug access.

Brandon Newman, PharmD, CSP, Program Director, Vanderbilt Specialty Pharmacy, talks about why the Certified Specialty Pharmacist distinction is significant.

EB-101 is the only gene therapy that has received this designation for Epidermolysis Bullosa.

Top news of the day from across the health care landscape.

Identifying and overcoming resistance to the use of generic HIV medications is becoming increasingly important to lower drug costs.

The FDA updated the labeling for rilipivirine (Edurant) for the treatment of HIV-positive pregnant patients who were on stable treatment prior to conception and who are virologically suppressed.

Achilles Alon, PharmD, RPh, Director of Specialty Pharmacy, Co-owner of ACE-Rx Specialty Pharmacy, tackles some of the challenges in starting a new specialty pharmacy.

New Amazon health care venture may lead to more effective specialty drug management.

HIV test can distinguish the prevalence of antibodies corresponding with a new or established infection.

Top news of the week from Specialty Pharmacy Times.

Obeticholic acid was incorrectly dosed daily instead of weekly in patients with moderate to severe primary biliary cholangitis, according to the FDA.

This weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings, and more. Our Week in Review is a can't miss for the busy pharmacy professional.

Prescription drug costs projected to increase 7.35% for health systems in 2018.

Newly-discovered gene mutations could double the risk of breast cancer.

A single blood test could diagnose 8 different types of cancer simultaneously.

Top news of the day from across the health care landscape.

The CDC finds people between the ages of 15 to 44 are significantly more likely to have never been tested for HIV.

Cuts to the 340B program may not negatively impact hospital reimbursement.

Kyle Truitt, Co-Founder, Turning Point, LLC, discusses the High-Performing Specialty Pharmacy Association.

Testing the social networks of patients newly-diagnosed with HIV could reveal other cases of the infection.

Sleep disturbances are common among patients with cancer and can persist for years posttreatment.

Top news of the day from across the health care landscape.

Stay up-to-date on market access news by visiting www.specialtyrxaccess.com

Combination antiretroviral therapy found to elevate the risk of heart attack and adverse effects on the cardiovascular system.

Out-of-pocket medical spending dropped an average of 12% under the Affordable Care Act.

Patients with a high risk of mortality may not choose first-line lung cancer treatment.

Fight or flight hormones could increase the production of tumor nerve cells.

Top news of the day from across the health care landscape.